These tumors typically have a higher neoantigenic load, a more significant tumor infiltrating lymphocyte infiltration, and are accompanied by upregulation of immune-related signals such as the PD-1-PD-L1 pathway, features that suggest they may have some immunotherapeutic potential (29–31). The gene discussed is CD274; the disease is neoplasm.